Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,072 | -126,357 | -88,973 | -55,197 | -25,444 |
| Depreciation Amortization | 572 | 496 | 109 | -107 | -9 |
| Accounts payable and accrued liabilities | -5,386 | 2,521 | -1,958 | -2,197 | -3,720 |
| Other Working Capital | -5,675 | -2,484 | 2 | 1,673 | -3,338 |
| Other Operating Activity | 10,823 | 14,400 | 12,947 | 8,765 | 6,481 |
| Operating Cash Flow | $-39,738 | $-111,424 | $-77,873 | $-47,063 | $-26,030 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -490 | -905 | -778 | -132 | -38 |
| Purchase Of Investment | -123,118 | -580,330 | -484,544 | -373,417 | -135,161 |
| Sale Of Investment | 112,401 | 372,334 | 162,253 | 82,253 | 16,450 |
| Investing Cash Flow | $-11,207 | $-208,901 | $-323,069 | $-291,296 | $-118,749 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -32,208 | N/A | N/A | N/A |
| Common Stock Issued | 1,235 | 184,702 | 183,606 | 183,139 | 911 |
| Financing Cash Flow | $1,235 | $152,494 | $183,606 | $183,139 | $911 |
| Beginning Cash Position | 166,926 | 334,757 | 334,757 | 334,757 | 334,757 |
| End Cash Position | 117,216 | 166,926 | 117,421 | 179,537 | 190,889 |
| Net Cash Flow | $-49,710 | $-167,831 | $-217,336 | $-155,220 | $-143,868 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,738 | -111,424 | -77,873 | -47,063 | -26,030 |
| Capital Expenditure | -490 | -946 | -807 | -161 | -38 |
| Free Cash Flow | -40,228 | -112,370 | -78,680 | -47,224 | -26,068 |